Success Metrics

Clinical Success Rate
50.0%

Based on 3 completed trials

Completion Rate
50%(3/6)
Active Trials
1(13%)
Results Posted
67%(2 trials)
Terminated
3(38%)

Phase Distribution

Ph early_phase_1
1
13%
Ph phase_2
2
25%
Ph not_applicable
1
13%

Phase Distribution

1

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Early Phase 1First-in-human
1(25.0%)
Phase 2Efficacy & side effects
2(50.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

50.0%

3 of 6 finished

Non-Completion Rate

50.0%

3 ended early

Currently Active

1

trials recruiting

Total Trials

8

all time

Status Distribution
Active(2)
Completed(3)
Terminated(3)

Detailed Status

Completed3
Terminated3
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
1
Success Rate
50.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (25.0%)
Phase 22 (50.0%)
N/A1 (25.0%)

Trials by Status

completed338%
not_yet_recruiting113%
terminated338%
recruiting113%

Recent Activity

1 active trials
Showing 5 of 8
completedphase_2

Imaging in MGUS, SMM and MM

NCT01237054
completed

ICG Fluorescence Imaging in Post-traumatic Infection

NCT04403204
not_yet_recruiting

Application of Multimodal MRI-based Radiomics in Histological Grading and Prognostic Assessment of Breast Cancer

NCT07389200
recruiting

StrokeCog-BBB to Study Cognitive Outcomes Following Stroke

NCT06116630
terminated

Metastatic Colorectal Cancer: Treatment Response With Dynamic Contrast MRI

NCT00820456
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT01237054Phase 2

Imaging in MGUS, SMM and MM

Completed
NCT04403204

ICG Fluorescence Imaging in Post-traumatic Infection

Completed
NCT07389200

Application of Multimodal MRI-based Radiomics in Histological Grading and Prognostic Assessment of Breast Cancer

Not Yet Recruiting
NCT06116630

StrokeCog-BBB to Study Cognitive Outcomes Following Stroke

Recruiting
NCT00820456

Metastatic Colorectal Cancer: Treatment Response With Dynamic Contrast MRI

Terminated
NCT01996527Early Phase 1

3T MRI Biomarkers of Glioma Treatment Response

Terminated
NCT00490061Phase 2

Lapatinib and Radiation for Stage III-IV Head and Neck Cancer Patients Who Cannot Tolerate Concurrent Chemotherapy

Terminated
NCT00598741Not Applicable

Dynamic Contrast Enhanced MRI(DCE-MRI)of Bone Tumors

Completed

All 8 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
8